Inventiva Sa - Adr Share Price (NASDAQ: IVA)

$6.24

▲

-0.11

(-1.73%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Inventiva Sa - Adr Stock chart to analyse performance

Inventiva Sa - Adr stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$5.77
Today's High:$6.25
$6.24
7.53%
Downside
Day's Volatility :7.68%
Upside
0.16%
52 Weeks Low:$1.53
52 Weeks High:$6.50
$6.24
75.48%
Downside
52 Weeks Volatility :76.46%
Upside
4.0%

Inventiva Sa - Adr Stock Returns

Period	Inventiva Sa - Adr	Sector (Health Care)	Index (Russel 2000)
3 Months	84.07%	3.6%	0.0%
6 Months	110.81%	-7.7%	0.0%
1 Year	168.39%	-12.6%	0.0%
3 Years	41.82%	10.2%	-4.1%

Inventiva Sa - Adr Key Stats

Check Inventiva Sa - Adr key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$6.35
Open	$5.89
Today's High	$6.25
Today's Low	$5.77
Market Capitalization	$883.0M
Today's Volume	$189.4K
52 Week High	$6.4999
52 Week Low	$1.53
Revenue TTM	$14.1M
EBITDA	$-93.8M
Earnings Per Share (EPS)	$-3.58
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-1642.76%

Stock Returns calculator for Inventiva Sa - Adr Stock including INR - Dollar returns

The Inventiva Sa - Adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Inventiva Sa - Adr investment value today

Current value as on today

₹2,73,095

Returns

₹1,73,095

(+173.1%)

Returns from Inventiva Sa - Adr Stock

₹1,67,811 (+167.81%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Inventiva Sa - Adr Stock

-17%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Inventiva Sa - Adr Stock from India on INDmoney has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Inventiva Sa - Adr

Name
Holdings %
Name
Holdings %
Yiheng Capital LLC
1.90%
NEA Management Company, LLC
1.05%
Bvf Inc
0.49%
Commonwealth Equity Services Inc
0.04%
Wealth Enhancement Advisory Services, LLC
0.01%
Creative Planning Inc
0.01%

Analyst Recommendation on Inventiva Sa - Adr Stock

Rating

Trend

Buy

92%Buy

7%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Inventiva Sa - Adr(by analysts ranked 0 to 5 stars)

Inventiva Sa - Adr Share Price Target

What analysts predicted

Upside of 104.86%

Target:

$12.78

Current:

$6.24

Inventiva Sa - Adr share price target is $12.78, a slight Upside of 104.86% compared to current price of $6.24 as per analysts' prediction.

Inventiva Sa - Adr Stock Insights

Price Movement
In the last 7 days, IVA stock has moved up by 39.4%
IVA vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 77.3%

Inventiva Sa - Adr Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$7.8M	↑ 118.89%
Net Income	$-33.6M	↓ 10.1%
Net Profit Margin	-431.85%	↑ 619.64%

	FY20	Y/Y Change
Revenue	$452.5K	↓ 94.68%
Net Income	$-38.5M	↑ 4.64%
Net Profit Margin	-8.5K%	↓ 8068.96%

	FY21	Y/Y Change
Revenue	$4.7M	↑ 1027.42%
Net Income	$-56.1M	↑ 56.96%
Net Profit Margin	-1.2K%	↑ 7317.31%

	FY22	Y/Y Change
Revenue	$12.9M	↑ 190.39%
Net Income	$-57.4M	↑ 9.34%
Net Profit Margin	-445.64%	↑ 737.86%

	FY23	Y/Y Change
Revenue	$19.1M	↑ 43.5%
Net Income	$-120.5M	↑ 103.46%
Net Profit Margin	-631.84%	↓ 186.2%

	FY24	Y/Y Change
Revenue	$9.6M	↓ 47.37%
Net Income	$-192.7M	↑ 66.82%
Net Profit Margin	-2.0K%	↓ 1370.9%

Q2 FY23

Q4 FY23

Q1 FY24

Q2 FY24

Q3 FY24

Q1 FY25

	Q2 FY23	Q/Q Change
Revenue	$6.6M	-
Net Income	$-55.3M	-
Net Profit Margin	-834.63%	-

	Q4 FY23	Q/Q Change
Revenue	$16.5M	↑ 149.79%
Net Income	$-55.2M	↓ 0.2%
Net Profit Margin	-333.46%	↑ 501.17%

	Q1 FY24	Q/Q Change
Revenue	$16.5M	↑ 0.0%
Net Income	$-55.2M	↑ 0.0%
Net Profit Margin	-333.46%	↑ 0.0%

	Q2 FY24	Q/Q Change
Revenue	$2.7M	↓ 83.47%
Net Income	$-49.0M	↓ 11.11%
Net Profit Margin	-1.8K%	↓ 1459.85%

	Q3 FY24	Q/Q Change
Revenue	$2.7M	↑ 0.0%
Net Income	$-49.0M	↑ 0.0%
Net Profit Margin	-1.8K%	↑ 0.0%

	Q1 FY25	Q/Q Change
Revenue	$6.5M	↑ 136.43%
Net Income	$-135.2M	↑ 175.72%
Net Profit Margin	-2.1K%	↓ 298.01%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$7.8M	↑ 213.81%

	FY20	Y/Y Change
Profit	$452.5K	↓ 94.68%

	FY21	Y/Y Change
Profit	$3.6M	↑ 754.03%

	FY22	Y/Y Change
Profit	$12.9M	↑ 283.35%

	FY23	Y/Y Change
Profit	$19.1M	↑ 43.69%

	FY24	Y/Y Change
Profit	$9.6M	↓ 47.44%

Q2 FY23

Q4 FY23

Q1 FY24

Q2 FY24

Q3 FY24

Q1 FY25

	Q2 FY23	Q/Q Change
Profit	$6.2M	-

	Q4 FY23	Q/Q Change
Profit	$16.0M	↑ 159.34%

	Q1 FY24	Q/Q Change
Profit	$16.0M	↑ 0.0%

	Q2 FY24	Q/Q Change
Profit	$2.7M	↓ 82.89%

	Q3 FY24	Q/Q Change
Profit	$2.2M	↓ 19.24%

	Q1 FY25	Q/Q Change
Profit	$7.0M	↑ 216.58%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-31.6M	↓ 16.96%
Investing Cash Flow	$-917.9K	↑ 96.67%
Financing Cash Flow	$9.3M	↓ 74.04%

	FY20	Y/Y Change
Operating Cash Flow	$-37.2M	↑ 7.7%
Investing Cash Flow	$-10.4M	↑ 935.96%
Financing Cash Flow	$135.8M	↑ 1232.94%

	FY21	Y/Y Change
Operating Cash Flow	$-53.8M	↑ 55.7%
Investing Cash Flow	$-2.0M	↓ 79.05%
Financing Cash Flow	$28.8M	↓ 77.21%

	FY22	Y/Y Change
Operating Cash Flow	$-47.5M	↓ 5.67%
Investing Cash Flow	$9.4M	↓ 594.59%
Financing Cash Flow	$39.4M	↑ 46.45%

	FY23	Y/Y Change
Operating Cash Flow	$-89.0M	↑ 81.66%
Investing Cash Flow	$-8.4M	↓ 187.18%
Financing Cash Flow	$31.7M	↓ 21.97%

	FY24	Y/Y Change
Operating Cash Flow	$-89.9M	↑ 5.29%
Investing Cash Flow	$9.1M	↓ 213.12%
Financing Cash Flow	$152.3M	↑ 400.64%

Q1 FY23

Q2 FY23

Q1 FY24

Q3 FY24

Q1 FY25

	Q1 FY23	Q/Q Change
Operating Cash Flow	$-22.6M	↑ 20.9%
Investing Cash Flow	$-3.9M	↓ 142.15%
Financing Cash Flow	$-1.1M	↓ 104.62%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-45.2M	↑ 100.0%
Investing Cash Flow	$-7.7M	↑ 100.0%
Financing Cash Flow	$-2.2M	↑ 100.0%

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-36.4M	↑ 0.0%
Investing Cash Flow	$-29.0K	-
Financing Cash Flow	$31.2M	↑ 0.0%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-48.3M	↑ 32.88%
Investing Cash Flow	$8.9M	↓ 30831.03%
Financing Cash Flow	$22.6M	↓ 27.75%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-37.6M	↓ 22.25%
Investing Cash Flow	$-167.0K	↓ 101.87%
Financing Cash Flow	$123.0M	↑ 445.13%

Inventiva Sa - Adr Technicals Summary

Sell

Neutral

Buy

Inventiva Sa - Adr is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Inventiva Sa - Adr Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Inventiva Sa - Adr	93.79%	110.81%	168.39%	41.82%	-55.43%
Regeneron Pharmaceuticals, Inc.	3.92%	-15.2%	-50.31%	-3.3%	-2.01%
Beone Medicines Ltd	2.49%	24.81%	62.78%	79.11%	29.69%
Vertex Pharmaceuticals Incorporated	-15.42%	-19.13%	-17.84%	34.68%	41.87%
Alnylam Pharmaceuticals, Inc.	11.08%	83.28%	75.87%	111.28%	242.25%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Inventiva Sa - Adr	NA	NA	NA	-1.05	-16.43	-0.64	NA	-1.11
Regeneron Pharmaceuticals, Inc.	14.6	14.6	1.2	39.42	0.15	0.07	0.0	287.55
Beone Medicines Ltd	NA	NA	NA	2.73	-0.05	-0.01	NA	34.32
Vertex Pharmaceuticals Incorporated	27.86	27.86	0.58	18.06	0.23	0.13	NA	67.02
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	3.92	-2.58	-0.03	NA	1.91

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Inventiva Sa - Adr	Buy	$883.0M	-55.43%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$61.4B	-2.01%	14.6	31.37%
Beone Medicines Ltd	NA	$36.5B	29.69%	NA	-3.89%
Vertex Pharmaceuticals Incorporated	Buy	$100.5B	41.87%	27.86	31.86%
Alnylam Pharmaceuticals, Inc.	Buy	$59.5B	242.25%	NA	-12.96%

About Inventiva Sa - Adr

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. The company develops Lanifibranor, a novel pan-peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. It also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. The company was incorporated in 2011 and is headquartered in Daix, France.

Organization	Inventiva Sa - Adr
Employees	114
CEO	Mr. Frederic Cren
Industry	Health Technology

Key Management of Inventiva Sa - Adr

Name	Title
Mr. Frederic Cren	Co-Founder, CEO & Director
Dr. Pierre Broqua Ph.D.	Co-Founder
Dr. Martine Zimmermann Pharm.D.	Executive VP of Regulatory Affairs and Quality Assurance & Director
Mr. Jean Volatier	Deputy GM & CFO
Ms. Alice Roudot-Ketelers Pharm.D.	Chief Operating Officer
Mr. Eric Duranson L.L.M.	General Counsel
Ms. Nathalie Harroy	Head of Human Resources
Ms. Pascaline Clerc Ph.D.	Executive Vice President of Strategy & Corporate Affairs
Dr. Jason A. Campagna M.D., Ph.D.	President of Research and Development & Chief Medical Officer

Important FAQs about investing in IVA Stock from India :

What is Inventiva Sa - Adr share price today?

Inventiva Sa - Adr share price today is $6.24 as on August 30, 2025 at 1:29 am IST at the close of the market. Inventiva Sa - Adr share today touched a day high of $6.25 and a low of $5.77.

What is the 52 week high and 52 week low for Inventiva Sa - Adr share?

Inventiva Sa - Adr share touched a 52 week high of $6.50 and a 52 week low of $1.53. Inventiva Sa - Adr stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $6.24, lower by 4% versus the 52 week high.

How to invest in Inventiva Sa - Adr Stock (IVA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Inventiva Sa - Adr on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Inventiva Sa - Adr Shares that will get you 0.2404 shares as per Inventiva Sa - Adr share price of $6.24 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Inventiva Sa - Adr Stock (IVA) from India?

Indian investors can start investing in Inventiva Sa - Adr (IVA) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Inventiva Sa - Adr stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Inventiva Sa - Adr share’s latest price of $6.24 as on August 30, 2025 at 1:29 am IST, you will get 1.6026 shares of Inventiva Sa - Adr. Learn more about fractional shares .

What are the returns that Inventiva Sa - Adr has given to Indian investors in the last 5 years?

Inventiva Sa - Adr stock has given -55.43% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?